Anti-REL3/ RLN3/ H3 functional antibody
Anti-REL3/ RLN3/ H3 functional antibody for cell culture, ELISA & in-vivo assay
Go to RLN3/RLN3 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-SE1243-Ab-1/ GM-Tg-hg-SE1243-Ab-2 | Anti-Human RLN3 monoclonal antibody | Human |
GM-Tg-rg-SE1243-Ab-1/ GM-Tg-rg-SE1243-Ab-2 | Anti-Rat RLN3 monoclonal antibody | Rat |
GM-Tg-mg-SE1243-Ab-1/ GM-Tg-mg-SE1243-Ab-2 | Anti-Mouse RLN3 monoclonal antibody | Mouse |
GM-Tg-cynog-SE1243-Ab-1/ GM-Tg-cynog-SE1243-Ab-2 | Anti-Cynomolgus/ Rhesus macaque RLN3 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-SE1243-Ab-1/ GM-Tg-felg-SE1243-Ab-2 | Anti-Feline RLN3 monoclonal antibody | Feline |
GM-Tg-cang-SE1243-Ab-1/ GM-Tg-cang-SE1243-Ab-2 | Anti-Canine RLN3 monoclonal antibody | Canine |
GM-Tg-bovg-SE1243-Ab-1/ GM-Tg-bovg-SE1243-Ab-2 | Anti-Bovine RLN3 monoclonal antibody | Bovine |
GM-Tg-equg-SE1243-Ab-1/ GM-Tg-equg-SE1243-Ab-2 | Anti-Equine RLN3 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-SE1243-Ab-1/ GM-Tg-hg-SE1243-Ab-2; GM-Tg-rg-SE1243-Ab-1/ GM-Tg-rg-SE1243-Ab-2; GM-Tg-mg-SE1243-Ab-1/ GM-Tg-mg-SE1243-Ab-2; GM-Tg-cynog-SE1243-Ab-1/ GM-Tg-cynog-SE1243-Ab-2; GM-Tg-felg-SE1243-Ab-1/ GM-Tg-felg-SE1243-Ab-2; GM-Tg-cang-SE1243-Ab-1/ GM-Tg-cang-SE1243-Ab-2; GM-Tg-bovg-SE1243-Ab-1/ GM-Tg-bovg-SE1243-Ab-2; GM-Tg-equg-SE1243-Ab-1/ GM-Tg-equg-SE1243-Ab-2 |
Products Name | Anti-RLN3 monoclonal antibody |
Format | mab |
Target Name | RLN3 |
Protein Sub-location | Secreted Protein/Potential Cytokines |
Category of antibody | FACS/Biofunctional Antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD). |
Tag | Fc |
Products description | Pre-made anti-RLN3 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | GM-Tg-g-SE1243-Ag-1 | Recombinant multi-species REL3/ RLN3/ H3 protein |
ORF Viral Vector | pGMLP005057 | human RLN3 Lentivirus plasmid |
ORF Viral Vector | vGMLP005057 | human RLN3 Lentivirus particle |
ORF Viral Vector | pGMLPm003515 | mouse Rln3 Lentivirus plasmid |
ORF Viral Vector | vGMLPm003515 | mouse Rln3 Lentivirus particle |
Target information
Target ID | GM-SE1243 |
Target Name | RLN3 |
Gene ID | 117579,212108,266997,717577,119864730,101090240,100300034,100630151 |
Gene Symbol and Synonyms | H3,insl7,M3,RLN3,RLX3,RXN3,ZINS4 |
Uniprot Accession | Q8WXF3,Q8BFS3 |
Uniprot Entry Name | REL3_HUMAN,REL3_RAT |
Protein Sub-location | Secreted Protein/Potential Cytokines |
Category | |
Disease | N/A |
Gene Ensembl | ENSG00000171136 |
Target Classification | N/A |
The target: RLN3, gene name: RLN3, also named as H3, RXN3, ZINS4, insl7. This gene encodes a member of the relaxin family of insulin-like hormones that is expressed predominantly in the brain and plays a role in physiological processes such as stress, memory and appetite regulation. The encoded protein is a precursor that is proteolytically processed to generate a heterodimeric mature form consisting A and B chains interlinked by disulfide bonds. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2015].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.